Center-Authored Papers

Filters: Author is Weisenberger, Daniel J  [Clear All Filters]
2017
Connolly RM, Li H, Jankowitz RC, Zhang Z, Rudek MA, Jeter SC, Slater SA, Powers P, Wolff AC, Fetting JH et al..  2017.  Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study.. Clinical cancer research : an official journal of the American Association for Cancer Research. 23(11):2691-2701. Abstract
2015
Levine JA, Phipps AI, Baron JA, Buchanan DD, Ahnen DJ, Cohen S, Lindor NM, Newcomb PA, Rosty C, Haile RW et al..  2015.  Clinicopathological risk factor distributions for MLH1 promoter region methylation in CIMP positive tumors.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Weisenberger DJ, Levine JA, Long TI, Buchanan DD, Walters R, Clendenning M, Rosty C, Joshi AD, Stern MC, Le Marchand L et al..  2015.  Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(3):512-9. Abstract
2013
Wrangle J, Wang W, Koch A, Easwaran H, Mohammad HP, Vendetti F, Vancriekinge W, Demeyer T, Du Z, Parsana P et al..  2013.  Alterations of immune response of non-small cell lung cancer with Azacytidine.. Oncotarget. 4(11):2067-79. Abstract
Samadder NJ, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, Lynch CF, Anderson KE, French AJ, Haile RW et al..  2013.  Associations Between Colorectal Cancer Molecular Markers and Pathways With Clinicopathologic Features in Older Women.. Gastroenterology. Abstract
2012
Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, Lynch CF, Anderson KE, French AJ, Haile RW et al..  2012.  Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women.. Gut. 61(9):1299-305. Abstract
Razzak AA, Oxentenko AS, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, Lynch CF, Anderson KE, French AJ et al..  2012.  Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa Women's Health Study.. Nutrition and cancer. 64(7):899-910. Abstract
2011
Rumilla K, Schowalter KV, Lindor NM, Thomas BC, Mensink KA, Gallinger S, Holter S, Newcomb PA, Potter JD, Jenkins MA et al..  2011.  Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated lynch syndrome cases.. The Journal of molecular diagnostics : JMD. 13(1):93-9. Abstract
2010
Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, Lynch CF, Anderson KE, French AJ, Haile RW et al..  2010.  Cigarette smoking and colorectal cancer risk by molecularly defined subtypes.. Journal of the National Cancer Institute. 102(14):1012-22. Abstract
2008
Poynter JN, Siegmund KD, Weisenberger DJ, Long TI, Thibodeau SN, Lindor N, Young J, Jenkins MA, Hopper JL, Baron JA et al..  2008.  Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(11):3208-15. Abstract